TW360653B - A oxadiazole compound having colon motility stimulating properties, its preparation process and its pharmaceutical composition - Google Patents

A oxadiazole compound having colon motility stimulating properties, its preparation process and its pharmaceutical composition

Info

Publication number
TW360653B
TW360653B TW085101860A TW85101860A TW360653B TW 360653 B TW360653 B TW 360653B TW 085101860 A TW085101860 A TW 085101860A TW 85101860 A TW85101860 A TW 85101860A TW 360653 B TW360653 B TW 360653B
Authority
TW
Taiwan
Prior art keywords
alkyl
hydrogen
dioxane
alk
aryl
Prior art date
Application number
TW085101860A
Other languages
English (en)
Inventor
Jean-Paul Rene Marie Andre Bosmans
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Application granted granted Critical
Publication of TW360653B publication Critical patent/TW360653B/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
TW085101860A 1995-03-01 1996-02-15 A oxadiazole compound having colon motility stimulating properties, its preparation process and its pharmaceutical composition TW360653B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP95200501 1995-03-01

Publications (1)

Publication Number Publication Date
TW360653B true TW360653B (en) 1999-06-11

Family

ID=8220055

Family Applications (1)

Application Number Title Priority Date Filing Date
TW085101860A TW360653B (en) 1995-03-01 1996-02-15 A oxadiazole compound having colon motility stimulating properties, its preparation process and its pharmaceutical composition

Country Status (25)

Country Link
US (1) US5854261A (zh)
EP (1) EP0812321B1 (zh)
JP (1) JP3980056B2 (zh)
KR (1) KR100443554B1 (zh)
CN (1) CN1092656C (zh)
AR (1) AR003932A1 (zh)
AT (1) ATE384716T1 (zh)
AU (1) AU702932B2 (zh)
BR (1) BR9607316A (zh)
CA (1) CA2212893C (zh)
CZ (1) CZ286992B6 (zh)
DE (1) DE69637412T2 (zh)
EA (1) EA001084B1 (zh)
ES (1) ES2301166T3 (zh)
FI (1) FI973562A (zh)
HU (1) HUP9702395A3 (zh)
IL (1) IL117315A (zh)
MY (1) MY113584A (zh)
NO (1) NO309425B1 (zh)
NZ (1) NZ301699A (zh)
PL (1) PL183712B1 (zh)
TR (1) TR199700876T1 (zh)
TW (1) TW360653B (zh)
WO (1) WO1996026937A1 (zh)
ZA (1) ZA961652B (zh)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9603755D0 (en) * 1996-02-22 1996-04-24 Pfizer Ltd Therapeutic agents
US6107313A (en) * 1998-10-02 2000-08-22 Combichem, Inc. Dopamine receptor antagonists
US7332508B2 (en) * 2002-12-18 2008-02-19 Novo Nordisk A/S Substituted homopiperidine, piperidine or pyrrolidine derivatives
GB0910667D0 (en) * 2009-06-19 2009-08-05 Glaxo Wellcome Mfg Pte Ltd Novel compounds
DK2758394T3 (en) 2011-09-19 2015-04-20 Suven Life Sciences Ltd HETEROARYL COMPOUNDS AS 5-HT4 RECEPTOR LIGANDS
JP2019533022A (ja) * 2016-10-24 2019-11-14 ユマニティ セラピューティクス，インコーポレーテッド 化合物及びその使用
CA3083000A1 (en) 2017-10-24 2019-05-02 Yumanity Therapeutics, Inc. Compounds and uses thereof

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1183847A (en) * 1981-10-01 1985-03-12 Georges Van Daele N-(3-hydroxy-4-piperidinyl)benzamide derivatives
US5374637A (en) * 1989-03-22 1994-12-20 Janssen Pharmaceutica N.V. N-(3-hydroxy-4-piperidinyl)(dihydrobenzofuran, dihydro-2H-benzopyran or dihydrobenzodioxin)carboxamide derivatives
GB9005014D0 (en) * 1990-03-06 1990-05-02 Janssen Pharmaceutica Nv N.(4.piperidinyl)(dihydrobenzofuran or dihydro.2h.benzopyran)carboxamide derivatives
US5492919A (en) * 1991-08-03 1996-02-20 Smithkline Beecham P.L.C. 5-HT4 receptor antagonists
GB9202797D0 (en) * 1992-02-11 1992-03-25 Milsom Jonathan Glazed units
US5708174A (en) * 1992-03-12 1998-01-13 Smithkline Beecham P.L.C. Heterocyclic-esters or -amides used as 5-HT4 receptor antagonists
MX9306311A (es) * 1992-10-13 1994-04-29 Smithkline Beecham Plc Compuestos antagonistas del receptor de 5-ht4, procedimiento para su preparacion y composiciones farmaceuticas que los contienen
JPH08502741A (ja) * 1992-11-05 1996-03-26 スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー ５−ｈｔ▲下４▼レセプターアンタゴニスト用のピペリジン誘導体
JPH06157518A (ja) * 1992-11-27 1994-06-03 Yamanouchi Pharmaceut Co Ltd 新規なオキサジアゾール誘導体又はその塩
WO1995032965A1 (fr) * 1994-06-01 1995-12-07 Yamanouchi Pharmaceutical Co. Ltd. Derive de l'oxadiazole et composition medicinale a base de ce dernier

Also Published As

Publication number Publication date
AU4718896A (en) 1996-09-18
EP0812321B1 (en) 2008-01-23
AU702932B2 (en) 1999-03-11
JPH11501021A (ja) 1999-01-26
HUP9702395A2 (hu) 1999-09-28
KR100443554B1 (ko) 2004-10-06
ATE384716T1 (de) 2008-02-15
MY113584A (en) 2002-04-30
US5854261A (en) 1998-12-29
FI973562A0 (fi) 1997-08-29
CN1177352A (zh) 1998-03-25
NO973808L (no) 1997-08-19
CN1092656C (zh) 2002-10-16
EA199700205A1 (ru) 1998-02-26
KR19980702304A (ko) 1998-07-15
DE69637412T2 (de) 2009-01-22
PL322019A1 (en) 1998-01-05
MX9706622A (es) 1997-11-29
FI973562A (fi) 1997-08-29
NO309425B1 (no) 2001-01-29
WO1996026937A1 (en) 1996-09-06
DE69637412D1 (de) 2008-03-13
EP0812321A1 (en) 1997-12-17
CZ286992B6 (en) 2000-08-16
HUP9702395A3 (en) 1999-10-28
NO973808D0 (no) 1997-08-19
ZA961652B (en) 1997-09-11
BR9607316A (pt) 1997-12-30
IL117315A0 (en) 1996-06-18
ES2301166T3 (es) 2008-06-16
CA2212893A1 (en) 1996-09-06
PL183712B1 (pl) 2002-07-31
TR199700876T1 (xx) 1998-02-21
JP3980056B2 (ja) 2007-09-19
IL117315A (en) 2000-07-26
NZ301699A (en) 1998-02-26
CA2212893C (en) 2007-01-16
AR003932A1 (es) 1998-09-30
EA001084B1 (ru) 2000-10-30
CZ272397A3 (cs) 1998-02-18

Similar Documents

Publication Publication Date Title
NZ326354A (en) 3-(substituted-1-piperazinyl)-6-(substituted-1,2,4-thiadiazol-5 -yl)-pyridazine derivatives and medicaments
HUT75943A (en) Watersoluble azole antifungals, process for their preparation intermediates, and pharmaceutical compositions containing the compounds
BG104287A (en) Halogensubstituted tetracyclic derivatives of tetrahydrofuran
TW360653B (en) A oxadiazole compound having colon motility stimulating properties, its preparation process and its pharmaceutical composition
AU3608195A (en) N-substituted piperidinyl bicyclic benzoate derivatives
DE60324568D1 (en) Nicht-nucleoside revers-transcriptase inhibitoren
AP1396A (en) 1-Trifluoromethyl-4-hydroxy-7-piperidinylaminomethylchroman derivatives.
TR200103286T2 (tr) Projesteron reseptörü modülatörleri olarak siklokarbamat türevleri
MX9703074A (es) Inhibidores de sintesis de apoliproteina-b.
TW354295B (en) Phenyl-oxo-alkyl-(4-piperidinyl) benzoate derivatives
GB1090276A (en) Yohimbane derivatives

Legal Events

Date Code Title Description
MM4A Annulment or lapse of patent due to non-payment of fees